Last reviewed · How we verify
paraurethral injection of MDCs — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
paraurethral injection of MDCs (paraurethral injection of MDCs) — Royan Institute.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| paraurethral injection of MDCs TARGET | paraurethral injection of MDCs | Royan Institute | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- paraurethral injection of MDCs CI watch — RSS
- paraurethral injection of MDCs CI watch — Atom
- paraurethral injection of MDCs CI watch — JSON
- paraurethral injection of MDCs alone — RSS
Cite this brief
Drug Landscape (2026). paraurethral injection of MDCs — Competitive Intelligence Brief. https://druglandscape.com/ci/paraurethral-injection-of-mdcs. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab